United Therapeutics Corp. 13F holders
Of the 44 funds followed here, 10 reported a position in United Therapeutics Corp. in a 13F for the quarter ended 30 June 2026. The largest: Renaissance Technologies, 1.7 million shares worth $925.8 million, 1.3% of its reported book.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 1,708,739 | $925.8 million | 1.3% | -78,280 | trimmed | 30 June 2026 | 13F |
| Geode Capital Management | 996,598 | $538.9 million | 0.0% | -236,431 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 747,992 | $405.3 million | 0.0% | +50,149 | added | 30 June 2026 | 13F |
| Norges Bank | 694,753 | $376.4 million | 0.0% | held | 30 June 2026 | 13F | |
| Millennium Management | 485,074 | $262.8 million | 0.1% | +180,302 | added | 30 June 2026 | 13F |
| FMR LLC | 473,409 | $256.5 million | 0.0% | -54,937 | trimmed | 30 June 2026 | 13F |
| Baillie Gifford | 467,209 | $253.1 million | 0.2% | +39,082 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 201,159 | $109.0 million | 0.1% | +30,456 | added | 30 June 2026 | 13F |
| Bridgewater Associates | 111,326 | $60.3 million | 0.2% | +157 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 12,606 | $6.8 million | 0.0% | -27,970 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 14 August 2026 | 13G/A | Rothblatt Martine A and 1 other | 2.3 million | 5.3% | 30 June 2026 | passive, other (13d-1(d)) | EDGAR |
| 13 August 2026 | 13G/A | Wellington Management Group LLP and 5 others | 1.4 million | 3.2% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 30 April 2026 | 13G | Vanguard Capital Management and 1 other | 2.3 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 10 February 2026 | 13G | Wellington Management Group LLP and 5 others | 2.4 million | 5.7% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 31 August 2026 | 24 | $515.46 | SEC |
| 24 August 2026 | 468 | $513.12 | SEC |
| 21 August 2026 | 8,582 | $521.00 | SEC |
| 19 August 2026 | 100 | $518.27 | SEC |
| 7 August 2026 | 13 | $532.94 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 8,582 on 21 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to UTHR by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.